プロテオミクス：各種技術と世界市場

世界のプロテオミクス技術の市場規模は、2024年に276億ドルと評価されており、2025年の310億ドルから、2030年末には572億ドルに拡大すると見込まれています。

2025年から2030年にかけてのCAGRは13.0%と予測されています。

北米の市場規模は、2025年の125億ドルから、2030年末には236億ドルに拡大すると見込まれており、同期間のCAGRは13.6%とされています。

アジア太平洋地域の市場規模は、2025年の74億ドルから、2030年末には150億ドルに拡大すると見込まれており、同期間のCAGRは15.0%と予測されています。

当レポートでは、世界のプロテオミクスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場サマリー
• 概要
• 現在の市場シナリオ
• セグメント分析
• 地域分析
• 新興技術
• 結論

第2章 市場概要

• プロテオーム技術
• プロテオミクスのタイプ
• 発現プロテオミクス
• 構造プロテオミクス
• 機能プロテオミクス
• プロテオミクスワークフロー
• マクロ経済要因分析
• ポーターのファイブフォース分析

第3章 市場力学

• 市場力学
• 市場促進要因
• 研究開発への投資
• 個別化医療への移行
• 高齢化の進行と慢性疾患の増加
• 市場抑制要因
• 機器の高コストと熟練労働力の不足
• データ分析の複雑さ
• 市場機会
• 新興技術
• 統合的なアプローチ

第4章 規制状況

• 規制の概要
• 米国の規制
• 欧州の規制
• プロテオミクス標準イニシアチブ

第5章 新興技術と開発

• プロテオミクス市場における新興技術
• 質量分析の進歩
• 免疫ライゲーション
• シングルセルプロテオミクス
• プロテオミクスにおけるAIの応用
• 特許分析
• 主要出願者別の特許状況
• 国・地域別の特許保有状況
• 年別の特許件数推移
• 主なポイント

第6章 市場セグメンテーション分析

• 概要
• セグメンテーションの内訳
• 市場分析：プラットフォームタイプ別
• 質量分析
• バイオチップ
• 市場分析：用途別
• サマリー
• 医薬品の発見・開発
• 診断
• 調査
• 応用プロテオミクス
• 市場分析：製品タイプ別
• サマリー
• 消耗品
• 機器・ソフトウェア
• 地理的内訳
• 市場分析：地域別
• サマリー
• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 競合情報

• 概要
• 市場ランキング分析
• 戦略的取り組み
• 合併と買収
• 協定、協力、パートナーシップ
• 新製品

第8章 プロテオミクス技術産業における持続可能性：ESGの観点

• 環境・社会・ガバナンス：イントロダクション
• 持続可能性の動向と取り組み
• 環境パフォーマンス
• 社会的パフォーマンス
• ガバナンスパフォーマンス
• ESGリスク評価
• BCCによる総論

第9章 付録

• 調査手法
• 出典
• 略語
• 企業プロファイル
• AGILENT TECHNOLOGIES INC.
• ARRAYIT CORP.
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• CREATIVE PROTEOMICS
• DANAHER CORP.
• JEOL LTD.
• MERCK KGAA
• PROMEGA CORP.
• REVVITY
• SHIMADZU CORP.
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.
• WATERS CORP.
• 新興スタートアップ企業/市場ディスラプター

List of Tables

• Summary Table : Global Market for Proteomic Technologies, by Region, Through 2030
• Table 1 : Global Incidence and Mortality Rates of Cancer, by Region, 2022
• Table 2 : Granted Patents in Proteomics Technologies, 2023-2025
• Table 3 : Global Market for Proteomics Technologies, by Platform Type, Through 2030
• Table 4 : Global Market for Mass Spectrometry, by Region, Through 2030
• Table 5 : Global Market for Biochips, by Type, Through 2030
• Table 6 : Global Market for Protein Microarrays, by Array Type, Through 2030
• Table 7 : Global Market for Biochips, by Region, Through 2030
• Table 8 : Global Market for Proteomic Technologies, by Application Type, Through 2030
• Table 9 : Drug Targets Identified by Proteomics
• Table 10 : Global Market for Proteomics in Drug Discovery and Development, by Platform Type, Through 2030
• Table 11 : Global Market for Proteomics in Drug Discovery and Development, by Region, Through 2030
• Table 12 : Examples of LC-MS/MS-based FDA-Approved Tests in Clinical Laboratories
• Table 13 : Global Market for Proteomics in Diagnostics, by Platform Type, Through 2030
• Table 14 : Global Market for Proteomics in Diagnostics, by Region, Through 2030
• Table 15 : Global Market for Proteomics in Diagnostics, by Disease Type, Through 2030
• Table 16 : Global Market for Proteomics in Research, by Platform Type, Through 2030
• Table 17 : Global Market for Proteomics in Research, by Region, Through 2030
• Table 18 : Global Market for Applied Proteomics, by Region, Through 2030
• Table 19 : Global Market for Proteomic Technologies, by Product Type, Through 2030
• Table 20 : Global Market for Consumables, by Region, Through 2030
• Table 21 : Global Market for Instruments and Software, by Region, Through 2030
• Table 22 : Global Market for Proteomic Technologies, by Region, Through 2030
• Table 23 : North American Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 24 : North American Market for Biochips, by Type, Through 2030
• Table 25 : North American Market for Proteomic Technologies, by Application Type, Through 2030
• Table 26 : North American Market for Proteomic Technologies, by Product Type, Through 2030
• Table 27 : North American Market for Proteomic Technologies, by Country, Through 2030
• Table 28 : U.S. Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 29 : U.S. Market for Proteomic Technologies, by Application Type, Through 2030
• Table 30 : U.S. Market for Proteomic Technologies, by Product Type, Through 2030
• Table 31 : Canadian Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 32 : Canadian Market for Proteomic Technologies, by Application Type, Through 2030
• Table 33 : Canadian Market for Proteomic Technologies, by Product Type, Through 2030
• Table 34 : Mexican Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 35 : Mexican Market for Proteomic Technologies, by Application Type, Through 2030
• Table 36 : Mexican Market for Proteomic Technologies, by Product Type, Through 2030
• Table 37 : European Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 38 : European Market for Biochips, by Type, Through 2030
• Table 39 : European Market for Proteomic Technologies, by Application Type, Through 2030
• Table 40 : European Market for Proteomic Technologies, by Product Type, Through 2030
• Table 41 : European Market for Proteomic Technologies, by Country, Through 2030
• Table 42 : German Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 43 : German Market for Proteomic Technologies, by Application Type, Through 2030
• Table 44 : German Market for Proteomic Technologies, by Product Type, Through 2030
• Table 45 : U.K. Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 46 : U.K. Market for Proteomic Technologies, by Application Type, Through 2030
• Table 47 : U.K. Market for Proteomic Technologies, by Product Type, Through 2030
• Table 48 : French Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 49 : French Market for Proteomic Technologies, by Application Type, Through 2030
• Table 50 : French Market for Proteomic Technologies, by Product Type, Through 2030
• Table 51 : Italian Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 52 : Italian Market for Proteomic Technologies, by Application Type, Through 2030
• Table 53 : Italian Market for Proteomic Technologies, by Product Type, Through 2030
• Table 54 : Spanish Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 55 : Spanish Market for Proteomic Technologies, by Application Type, Through 2030
• Table 56 : Spanish Market for Proteomic Technologies, by Product Type, Through 2030
• Table 57 : Rest of European Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 58 : Rest of European Market for Proteomic Technologies, by Application Type, Through 2030
• Table 59 : Rest of European Market for Proteomic Technologies, by Product Type, Through 2030
• Table 60 : Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 61 : Asia-Pacific Market for Biochips, by Type, Through 2030
• Table 62 : Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030
• Table 63 : Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030
• Table 64 : Asia-Pacific Market for Proteomic Technologies, by Country, Through 2030
• Table 65 : Chinese Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 66 : Chinese Market for Proteomic Technologies, by Application Type, Through 2030
• Table 67 : Chinese Market for Proteomic Technologies, by Product Type, Through 2030
• Table 68 : Japanese Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 69 : Japanese Market for Proteomic Technologies, by Application Type, Through 2030
• Table 70 : Japanese Market for Proteomic Technologies, by Product Type, Through 2030
• Table 71 : Indian Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 72 : Indian Market for Proteomic Technologies, by Application Type, Through 2030
• Table 73 : Indian Market for Proteomic Technologies, by Product Type, Through 2030
• Table 74 : South Korean Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 75 : South Korean Market for Proteomic Technologies, by Application Type, Through 2030
• Table 76 : South Korean Market for Proteomic Technologies, by Product Type, Through 2030
• Table 77 : Australian Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 78 : Australian Market for Proteomic Technologies, by Application Type, Through 2030
• Table 79 : Australian Market for Proteomic Technologies, by Product Type, Through 2030
• Table 80 : Rest of Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 81 : Rest of Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030
• Table 82 : Rest of Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030
• Table 83 : RoW Market for Proteomic Technologies, by Platform Type, Through 2030
• Table 84 : RoW Market for Proteomic Technologies, by Application Type, Through 2030
• Table 85 : RoW Market for Biochips, by Type, Through 2030
• Table 86 : RoW Market for Proteomic Technologies, by Product Type, Through 2030
• Table 87 : RoW Market for Proteomic Technologies, by Sub-region, Through 2030
• Table 88 : Rank of Manufacturers in the Proteomics Technology Market, 2024
• Table 89 : Mergers and Acquisitions in the Proteomics Technology Industry, 2020-2025
• Table 90 : Agreements, Collaborations and Partnerships in the Proteomics Technology Industry, 2022-2025
• Table 91 : Product Introductions in the Proteomics Technology Market, 2023-2025
• Table 92 : Environmental Performance Initiatives in the Proteomics Industry
• Table 93 : Social Performance Initiatives in Proteomics Market
• Table 94 : Governance Performance Initiatives in the Proteomics Industry
• Table 95 : ESG Rankings for Proteomics Companies, 2025*
• Table 96 : Information Sources for this Report
• Table 97 : Abbreviations Used in this Report
• Table 98 : Agilent Technologies Inc.: Company Snapshot
• Table 99 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
• Table 100 : Agilent Technologies Inc.: Product Portfolio
• Table 101 : Agilent Technologies Inc: News/Key Developments, 2023 and 2024
• Table 102 : Arrayit Corp.: Company Snapshot
• Table 103 : Arrayit Corp.: Product Portfolio
• Table 104 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 105 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
• Table 106 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 107 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021 and 2023
• Table 108 : Bio-Techne: Company Snapshot
• Table 109 : Bio-Techne: Financial Performance, FY 2022 and 2023
• Table 110 : Bio-Techne: Product Portfolio
• Table 111 : Bio-Techne: News/Key Developments, 2024 and 2025
• Table 112 : Bruker: Company Snapshot
• Table 113 : Bruker: Financial Performance, FY 2023 and 2024
• Table 114 : Bruker: Product Portfolio
• Table 115 : Bruker: News/Key Developments, 2022-2025
• Table 116 : Creative Proteomics: Company Snapshot
• Table 117 : Creative Proteomics: Product Portfolio
• Table 118 : Danaher Corp.: Company Snapshot
• Table 119 : Danaher Corp.: Financial Performance, FY 2023 and 2024
• Table 120 : Danaher Corp.: Product Portfolio
• Table 121 : Danaher Corp.: News/Key Developments, 2024
• Table 122 : JEOL Ltd.: Company Snapshot
• Table 123 : JEOL Ltd.: Financial Performance, FY 2022 and 2023
• Table 124 : JEOL Ltd.: Product Portfolio
• Table 125 : JEOL Ltd.: News/Key Developments, 2023
• Table 126 : Merck KGaA: Company Snapshot
• Table 127 : Merck KGaA: Financial Performance, FY 2023 and 2024
• Table 128 : Merck KGaA: Product Portfolio
• Table 129 : Merck KGaA: News/Key Developments, 2023 and 2024
• Table 130 : Promega Corp.: Company Snapshot
• Table 131 : Promega Corp.: Product Portfolio
• Table 132 : Revvity: Company Snapshot
• Table 133 : Revvity: Financial Performance, FY 2023 and 2024
• Table 134 : Revvity: Product Portfolio
• Table 135 : Revvity: News/Key Developments, 2023 and 2024
• Table 136 : Shimadzu Corp.: Company Snapshot
• Table 137 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023
• Table 138 : Shimadzu Corp.: Product Portfolio
• Table 139 : Shimadzu Corp.: News/Key Developments, 2024 and 2025
• Table 140 : Standard BioTools: Company Snapshot
• Table 141 : Standard BioTools: Financial Performance, FY 2023 and 2024
• Table 142 : Standard BioTools: Product Portfolio
• Table 143 : Standard BioTools: News/Key Developments, 2024
• Table 144 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 145 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
• Table 146 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 147 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2025
• Table 148 : Waters Corp.: Company Snapshot
• Table 149 : Waters Corp.: Financial Performance, FY 2023 and 2024
• Table 150 : Waters Corp.: Product Portfolio
• Table 151 : Waters Corp.: News/Key Developments, 2023 and 2024
• Table 152 : Emerging Startups in the Global Proteomics Market

List of Figures

• Summary Figure : Share of Global Market for Proteomic Technologies, by Region, 2024
• Figure 1 : Bottom-Up and Top-Down Proteomics
• Figure 2 : Porter's Five Forces Analysis of the Market for Proteomic Technologies
• Figure 3 : Market Dynamics for Proteomics Technologies
• Figure 4 : Average Venture Funding for Biopharma Therapeutics and Platform Companies, 2010-2024
• Figure 5 : Pharmaceutical R&D Expenditures for the U.S., Europe, Japan and China, for 2010, 2020 and 2022
• Figure 6 : Personalized Medicines and All FDA Approvals, 2015-2023
• Figure 7 : Patents Related to Proteomics, by Applicant, 2021-March 2025
• Figure 8 : Share of Patents Related to Proteomics, by Country/Region, 2021-March 2025
• Figure 9 : Patents Related to Proteomics, by Year, 2010-March 2025
• Figure 10 : Share of Global Market for Proteomics Technologies, by Platform Type, 2024
• Figure 11 : Share of Global Market for Proteomics Technologies, by Application Type, 2024
• Figure 12 : Share of Global Market for Proteomics Technologies, by Platform Type, 2024
• Figure 13 : Share of Global Market for Proteomic Technologies, by Region, 2024
• Figure 14 : Share of North American Market for Proteomic Technologies, by Country, 2024
• Figure 15 : NIH Funding in Healthcare R&D, 2010-2023
• Figure 16 : Share of European Market for Proteomic Technologies, by Country, 2024
• Figure 17 : Share of Asia-Pacific Market for Proteomic Technologies, by Country, 2024
• Figure 18 : Share of RoW Market for Proteomic Technologies, by Sub-region, 2024
• Figure 19 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 20 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
• Figure 21 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
• Figure 23 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
• Figure 24 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
• Figure 25 : Bruker: Revenue Share, by Business Unit, FY 2024
• Figure 26 : Bruker: Revenue Share, by Country/Region, FY 2024
• Figure 27 : Danaher Corp.: Revenue Share, by Business Unit, FY 2024
• Figure 28 : Danaher Corp.: Revenue Share, by Country/Region, FY 2024
• Figure 29 : JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 30 : JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 31 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
• Figure 32 : Merck KGaA: Revenue Share, by Country/Region, FY 2024
• Figure 33 : Revvity: Revenue Share, by Business Unit, FY 2024
• Figure 34 : Revvity: Revenue Share, by Country/Region, FY 2024
• Figure 35 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
• Figure 36 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
• Figure 37 : Standard BioTools: Revenue Share, by Business Unit, FY 2024
• Figure 38 : Standard BioTools: Revenue Share, by Country/Region, FY 2024
• Figure 39 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 40 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
• Figure 41 : Waters Corp.: Revenue Share, by Business Unit, FY 2024
• Figure 42 : Waters Corp.: Revenue Share, by Country/Region, FY 2024

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

The North American market for proteomic technologies is projected to grow from $12.5 billion in 2025 to $23.6 billion by the end of 2030, at a CAGR of 13.6% from 2025 to 2030.

The Asia-Pacific market for proteomic technologies is projected to grow from $7.4 billion in 2025 to $15.0 billion by the end of 2030, at a CAGR of 15.0% from 2025 to 2030.

Report Scope

The report analyzes trends in the global market for proteomic technologies market. It includes global revenues ($ millions) for the base year of 2024, estimates for 2025 and forecasts for 2025 through 2030. The market is segmented by product type, application, platform and region. Protein structural analysis and protein-expression products are outside the scope of the report. Product types include instruments and software, and consumables. Platforms include mass spectrometry and biochip. Applications include drug discovery and development, research, diagnostics, and applied proteomics. Regions are North America, Europe, Asia-Pacific and the Rest of the World (RoW). North America includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. RoW includes the Middle East and Africa (MEA) and South America.

The report focuses on the trends and challenges that affect the market and vendor landscape. It discusses emerging technologies and includes an analysis of the market shares of the leading companies. It offers a chapter on environmental, social, and corporate governance (ESG) developments. Its section on company profiles covers details such as financials, product portfolio, and recent developments.

Report Includes

• 97 data tables and 56 additional tables
• An overview of the global markets for proteomics and related technologies
• Analyses of the global market trends, with historic market revenue data from 2022 to 2024, estimates for 2025 and projected CAGRs through 2030
• Estimates of the actual market size and forecasts for proteomics, and a corresponding market share analysis by platform type, application, product type, and region
• In-depth facts and figures concerning market dynamics, technology advances, new products and applications for proteomics
• Discussion of patents and emerging technologies
• ESG trends in the industry
• Insight into the industry structure for proteomics technologies, competitive aspects of each product segment, companies' growth strategies, and a company value share analysis
• Updated information on mergers and acquisitions, agreements, partnerships and new products in the global proteomics industry
• Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher, Agilent Technologies Inc., Bruker and Waters Corp.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Proteomic Technologies
• Types of Proteomics
• Expression Proteomics
• Structural Proteomics
• Functional Proteomics
• Proteomics Workflow
• Macroeconomic Factors Analysis
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Threat of Substitute Products or Services
• Potential for New Entrants
• Industry Competitiveness

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Investments in R&D
• Transition To Personalized Medicines
• Rising Aging Population and the Growing Prevalence of Chronic Diseases
• Market Restraints
• High Cost of Instruments and Lack of Skilled Workforce
• Complexity of Data Analysis
• Market Opportunities
• Emerging Technologies
• Integrative Approaches

Chapter 4 Regulatory Landscape

• Regulatory Overview
• Regulations in the U.S.
• Regulations in Europe
• Proteomics Standards Initiative

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies in the Proteomics Market
• Advances in Mass Spectrometry
• Immuno-Ligation
• Single-cell Proteomics
• Application of AI in Proteomics
• Patent Analysis
• Patents, by Top Applicants
• Patents, by Assignee Country/Region
• Patents, by Year
• Key Takeaways

Chapter 6 Market Segmentation Analysis

• Overview
• Segmentation Breakdown
• Market Analysis by Platform Type
• Mass Spectrometry
• Biochips
• Market Analysis by Application
• Takeaways
• Drug Discovery and Development
• Diagnostics
• Research
• Applied Proteomics
• Market Analysis by Product Type
• Takeaways
• Consumables
• Instruments and Software
• Geographic Breakdown
• Market Analysis by Region
• Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Overview
• Market Ranking Analysis
• Strategic Initiatives
• Mergers and Acquisitions
• Agreements, Collaborations and Partnerships
• New Products

Chapter 8 Sustainability in the Proteomics Technology Industry: ESG Perspective

• Introduction to Environmental, Social and Governance
• Sustainability Trends and Initiatives
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• ARRAYIT CORP.
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• CREATIVE PROTEOMICS
• DANAHER CORP.
• JEOL LTD.
• MERCK KGAA
• PROMEGA CORP.
• REVVITY
• SHIMADZU CORP.
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.
• WATERS CORP.
• Emerging Start-ups/Market Disruptors